Table 2. Primary and Secondary Clinical Outcomes^a.

Outcome	Patients, %		Effect variable	Odds ratio (95% CI)
	DTAS (n = 74)	DTCT (n = 73)		Unadjusted	Adjusted
Shift analysis
90-d mRS scoreb	NA	NA	Common odds ratio	2.0 (1.1-3.7)	2.2 (1.2-4.1)
90-d mRS score (unified 5-6)	NA	NA	Common odds ratio	2.1 (1.2-3.7)	2.2 (1.2-4.0)
90-d mRS score
0-2	43.2	27.4	Odds ratio	2.0 (1.0-4.0)	2.0 (0.8-4.8)
0-3	58.1	45.2	Odds ratio	1.7 (0.9-3.2)	1.9 (0.8-4.3)
90-d mortalitya	21.3	32.9	Odds ratio	0.6 (0.3-1.1)	0.5 (0.2-1.2)

Abbreviations: DTAS, direct transfer to angiography suite; DTCT, direct transfer to computed tomography; mRS, modified Rankin Scale; NA, not applicable.

^aPrimary and secondary efficacy outcomes were evaluated in the modified intention-to-treat population, defined as patients with large vessel occlusion, whereas 90-day mortality was evaluated in all patients. The DTAS protocol improved clinical outcome, showing an adjusted common odds ratio of improvement of 1 point on the mRS score of 2.2.

^bThe mRS scores of functional disability range from 0 (no symptoms) to 6 (death), with a score of 2 or lower indicating functional independence.